Apart from balancing cell redox state, Trx1 can inhibit apoptosis by binding and blocking the activity of Apoptosis Signal-Regulating Kinase 1 (ASK1), decreasing cell response to anti-cancer drugs [107–110]. Here, MAP3K5 is linked to cancer.